Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 5 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Verrica Pharmaceuticals Inc have a median target of 13.50, with a high estimate of 18.00 and a low estimate of 12.00. The median estimate represents a 629.73% increase from the last price of 1.85.
High | 873.0% | 18.00 |
Med | 629.7% | 13.50 |
Low | 548.6% | 12.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 07, 2024.
Average growth rate | -22.56% |
Average growth rate | -22.07% |
More ▼
Revenue history & estimates in USD
Average growth rate | +399.67% |
Average growth rate | -22.67% |
More ▼